253 related articles for article (PubMed ID: 12878565)
21. Minimally immunogenic decellularized porcine valve provides in situ recellularization as a stentless bioprosthetic valve.
Iwai S; Torikai K; Coppin CM; Sawa Y
J Artif Organs; 2007; 10(1):29-35. PubMed ID: 17380294
[TBL] [Abstract][Full Text] [Related]
22. [Experimental study of xenogeneic heart valve material].
Shi KH; Zhang X; Zhang JF
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2003 Nov; 17(6):496-500. PubMed ID: 14663952
[TBL] [Abstract][Full Text] [Related]
23. Successful endothelialization of porcine glutaraldehyde-fixed aortic valves in a heterotopic sheep model.
Gulbins H; Pritisanac A; Pieper K; Goldemund A; Meiser BM; Reichart B; Daebritz S
Ann Thorac Surg; 2006 Apr; 81(4):1472-9. PubMed ID: 16564295
[TBL] [Abstract][Full Text] [Related]
24. Enhancement of mesenchymal stem cell attachment to decellularized porcine aortic valve scaffold by in vitro coating with antibody against CD90: a preliminary study on antibody-modified tissue-engineered heart valve.
Ye X; Zhao Q; Sun X; Li H
Tissue Eng Part A; 2009 Jan; 15(1):1-11. PubMed ID: 18759669
[TBL] [Abstract][Full Text] [Related]
25. Development of an in vivo tissue-engineered, autologous heart valve (the biovalve): preparation of a prototype model.
Hayashida K; Kanda K; Yaku H; Ando J; Nakayama Y
J Thorac Cardiovasc Surg; 2007 Jul; 134(1):152-9. PubMed ID: 17599501
[TBL] [Abstract][Full Text] [Related]
26. Bioengineering strategies for polymeric scaffold for tissue engineering an aortic heart valve: an update.
Morsi YS
Int J Artif Organs; 2014 Sep; 37(9):651-67. PubMed ID: 25262629
[TBL] [Abstract][Full Text] [Related]
27. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells.
Fang NT; Xie SZ; Wang SM; Gao HY; Wu CG; Pan LF
Chin Med J (Engl); 2007 Apr; 120(8):696-702. PubMed ID: 17517187
[TBL] [Abstract][Full Text] [Related]
28. [Preparation of heart valve scaffold and cell seeding].
Long L; Wu C; Pan L; Qi X; Hong T
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Aug; 21(4):610-3. PubMed ID: 15357443
[TBL] [Abstract][Full Text] [Related]
29. [Hemodynamic performance of newly developed composite stentless porcine aortic valve: in vitro testing and in vivo experiment with sheep].
Song GM; Zhou JY; Hu SS; Cui JW; Song YH; Tang Y; Zhang Y; Jiang H; Yuan WM; Song XY
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2059-63. PubMed ID: 19080436
[TBL] [Abstract][Full Text] [Related]
30. Tissue engineering of cardiac valves: re-seeding of acellular porcine aortic valve matrices with human mesenchymal progenitor cells.
Knight RL; Booth C; Wilcox HE; Fisher J; Ingham E
J Heart Valve Dis; 2005 Nov; 14(6):806-13. PubMed ID: 16359063
[TBL] [Abstract][Full Text] [Related]
31. Calcification resistance of procyanidin-treated decellularized porcine aortic valves in vivo.
Liu Y; Liu W; Sun G; Wei X; Yi D
Heart Surg Forum; 2009 Jan; 12(1):E24-9. PubMed ID: 19233761
[TBL] [Abstract][Full Text] [Related]
32. Non-Cytotoxic Crosslinkers for Heart Valve Tissue Engineering.
Somers P; Roosens A; De Somer F; Cornelissen M; Van Nooten G
J Heart Valve Dis; 2015 Jan; 24(1):92-100. PubMed ID: 26182626
[TBL] [Abstract][Full Text] [Related]
33. Tissue-engineered heart valve leaflets: an animal study.
Kim WG; Cho SK; Kang MC; Lee TY; Park JK
Int J Artif Organs; 2001 Sep; 24(9):642-8. PubMed ID: 11693421
[TBL] [Abstract][Full Text] [Related]
34. Orthotopic replacement of the aortic valve with decellularized allograft in a sheep model.
Baraki H; Tudorache I; Braun M; Höffler K; Görler A; Lichtenberg A; Bara C; Calistru A; Brandes G; Hewicker-Trautwein M; Hilfiker A; Haverich A; Cebotari S
Biomaterials; 2009 Oct; 30(31):6240-6. PubMed ID: 19703713
[TBL] [Abstract][Full Text] [Related]
35. Microstructured Nickel-Titanium Thin Film Leaflets for Hybrid Tissue Engineered Heart Valves Fabricated by Magnetron Sputter Deposition.
Loger K; Engel A; Haupt J; Lima de Miranda R; Lutter G; Quandt E
Cardiovasc Eng Technol; 2016 Mar; 7(1):69-77. PubMed ID: 26743538
[TBL] [Abstract][Full Text] [Related]
36. Comparative study of cellular and extracellular matrix composition of native and tissue engineered heart valves.
Schenke-Layland K; Riemann I; Opitz F; König K; Halbhuber KJ; Stock UA
Matrix Biol; 2004 May; 23(2):113-25. PubMed ID: 15246110
[TBL] [Abstract][Full Text] [Related]
37. Cell characterization of porcine aortic valve and decellularized leaflets repopulated with aortic valve interstitial cells: the VESALIO Project (Vitalitate Exornatum Succedaneum Aorticum Labore Ingenioso Obtenibitur).
Bertipaglia B; Ortolani F; Petrelli L; Gerosa G; Spina M; Pauletto P; Casarotto D; Marchini M; Sartore S;
Ann Thorac Surg; 2003 Apr; 75(4):1274-82. PubMed ID: 12683575
[TBL] [Abstract][Full Text] [Related]
38. Decellularized heart valve as a scaffold for in vivo recellularization: deleterious effects of granulocyte colony-stimulating factor.
Juthier F; Vincentelli A; Gaudric J; Corseaux D; Fouquet O; Calet C; Le Tourneau T; Soenen V; Zawadzki C; Fabre O; Susen S; Prat A; Jude B
J Thorac Cardiovasc Surg; 2006 Apr; 131(4):843-52. PubMed ID: 16580443
[TBL] [Abstract][Full Text] [Related]
39. Tissue-engineered heart valves: intra-operative protocol.
Gallo M; Bianco R; Bottio T; Naso F; Franci P; Zanella F; Perona G; Busetto R; Spina M; Gandaglia A; Gerosa G
J Cardiovasc Transl Res; 2013 Aug; 6(4):660-1. PubMed ID: 23765554
[TBL] [Abstract][Full Text] [Related]
40. Heart valve engineering: decellularized aortic homograft seeded with human cardiac stromal cells.
Dainese L; Guarino A; Burba I; Esposito G; Pompilio G; Polvani G; Rossini A
J Heart Valve Dis; 2012 Jan; 21(1):125-34. PubMed ID: 22474754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
